@FierceMedDev: ICYMI yesterday: Pentax backs $8M+ round for electrosurgery startup Creo. Article | Follow @FierceMedDev
@EmilyWFierce: Report: Cancer drug spending fuels large increases in Medicare discount drug program. ICYMI from FiercePharma | Follow @EmilyWFierce
> Meditation app maker HeadSpace has raised $34.1 million to create "a personal trainer for your mind." SEC filing
> Private equity firm Advent will buy 13% of the Brazilian medical diagnostics company Fleury. Story
> The National Science Foundation will spend $81 million over the next 5 years to support 16 sites conducting advanced nano-scale research; it will be coordinated by a new agency, the National Nanotechnology Coordinated Infrastructure (NNCI). More
Biotech News
@FierceBiotech: Aerie skyrockets on a mixed success in second PhIII glaucoma study. Article | Follow @FierceBiotech
@JohnCFierce: First on Fierce: OrbiMed sets its sights on a $950M blockbuster biotech fund. News | Follow @JohnCFierce
> A player in J&J's hep C cocktail helps hustle a quick cure. Story
> FDA: Those worries about Addyi and alcohol? We can handle it. More
> Lehmann leaves GSK to head up immuno-oncology at Celyad. Article
Pharma News
@FiercePharma: ViroVet spins out of Aratana with focus on livestock health. FierceAnimalHealth story | Follow @FiercePharma
@CarlyHFierce: ICYMI yesterday: BMS' Opdivo guns for kidney cancer nod with FDA 'breakthrough' tag. Article | Follow @CarlyHFierce
> BMJ: New analysis shows increased suicide rates in teens taking GSK's Paxil. More
> Celgene's Abraxane takes another hit from cost-effectiveness gatekeepers. Story
> Newly vocal union targets Big Pharma's payments to AHA and its leaders. Article
Vaccines News
> Takeda joins consortium that accelerates R&D for malaria, TB vaccines. Item
> Vaxent and PREVENT kick off Strep A vaccine trials. More
> Emory team to look at GSK vax response as part of NIH research. Report
> FDA panel recommends Fluad, possibly the first U.S. boosted flu jab. Story
> J&J's Janssen strikes four-year, $28.5M government partnership to advance Ebola vaccine. Article
CRO News
> PRA adding 150 jobs amid Pennsylvania expansion push. Report
> Chiltern closes its Theorem buy, doubling its workforce. Item
> Accelovance inks a nonprofit partnership for melanoma trials. Article
> WuXi brings its genomic heft to Chinese patients with hospital pact. Story
> Evotec upsizes its 2015 projections after a string of partnering deals. Article
Pharma Manufacturing News
> Pfizer Chinese JV partner Zhejiang Hisun Pharma gets FDA warning letter. More
> Nexvet picks up biologics plant in Ireland. Item
> FDA castigates Indian drugmaker over mess at API plant. Report
> Hamburg's pick in line to take over as FDA commissioner. Story
> FDA sears maker of GolfersSkin Sunscreen in warning letter. Article
Pharma Asia News
> Taiwan's TWi Pharmaceuticals raises $87M via GDR in weak pricing. Report
> China's Yabao Pharmaceutical adds to a summer string of tie-ups. Item
> Dual-listed Benitec adds fourth site for hep C trials of TT-034. More
> Low-cost genomic sequencing on the slate for China with Veritas landing? Story
> India's Glenmark says breast cancer candidate GBR 1302 moving to PhI. Article